Live-Cell Invasive Phenotyping Uncovers ALK2 as a Therapeutic Target in LKB1-Mutant Lung Cancer. Koo J, Seong CS, Parker RE, Herrera A, et al. Cancer Res 2024 Aug 29. doi: 10.1158/0008-5472.CAN-23-2631.

Read + Share

Amedeo Smart

Independent Medical Education

Koo J, Seong CS, Parker RE, Herrera A, et al. Live-Cell Invasive Phenotyping Uncovers ALK2 as a Therapeutic Target in LKB1-Mutant Lung Cancer. Cancer Res 2024 Aug 29. doi: 10.1158/0008-5472.CAN-23-2631.
PMID: 39207369